Clinical Trials
705 trialsAutologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
National Institutes of Health Clinical Center (CC)
Firmonertinib in Perioperative Treatment of Resectable Stage II-IIIB EGFR-mutated Lung Adenocarcinoma
Peking University Cancer Hospital & Institute
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung Cancer
Akeso
A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors
Huahui Health
ALINEAR
AstraZeneca
DIASTAG
AstraZeneca
AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer
Chugai Pharmaceutical
Selective Mediastinal Lymph Node Sampling Versus Systematic medIastinal Lymph Node Dissection After Neoadjuvant Chemoimmunotherapy for Non-small Cell Lung Cancer (SCIENCE Study)
Guangdong Provincial People's Hospital
ANASTASIA
AstraZeneca
Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma
Xuanwu Hospital, Beijing
A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung Cancer.
Hangzhou DAC Biotechnology Co., Ltd.
Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC.
Shanghai Pulmonary Hospital, Shanghai, China
Genomet
AstraZeneca
Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 in Combination With Ivonescimab in Sq-NSCLC Patients
Everest Medicines (China) Co.,Ltd.
Circulating Tumor DNA Mutations and Methylation Status as Biomarkers for Early Detection of Lung Cancer in Patients With Suspicious Lung Nodules
The University of Hong Kong
An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial
Fred Hutchinson Cancer Center
WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I)
WestVac Biopharma Co., Ltd.
CALMS-1
University of Texas Southwestern Medical Center
A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
Jazz Pharmaceuticals
LungSMART
University of Utah
LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B
Massachusetts General Hospital
Hypofractionated Chemoradiotherapy With Tislelizumab and Surufatinib for Unresectable Stage III NSCLC
Sun Yat-sen University
A Clinical Study of SCTB41 Combined With Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer(Phase II Study Ongoing)
Sinocelltech Ltd.
ICARE-LCS
VA Office of Research and Development
CURB-TKI
University Health Network, Toronto
FLINN
Washington University School of Medicine
A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial
Fred Hutchinson Cancer Center
A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment
Shandong Suncadia Medicine Co., Ltd.
SELECTmeso
University of Southampton
Sintilimab Plus Chemotherapy as Induction Therapy for Unresectable Stage IIIC NSCLC
Sun Yat-sen University
Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK202 for Injection in Combination With Drugs in NSCLC Participants.
Shanghai Allink Biotherapeutics Co., Ltd.
REVIVE
University of Chicago
Real-Time IGRT
University of Sydney
IMPULSION
Assistance Publique - Hôpitaux de Paris
PVD-Lungs
International Agency for Research on Cancer
Repotrectinib Post-Marketing Surveillance in Korean Patients With ROS1-Positive Non-Small Cell Lung Cancer (NSCLC) or Solid Tumors Harboring a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion
Bristol-Myers Squibb
Oral Paclitaxel as Neoadjuvant Therapy in Elderly NSCLC: A Phase II Trial
Shanghai Pulmonary Hospital, Shanghai, China
Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab
Boehringer Ingelheim
Construction and Preliminary Evaluation of Dyadic Acceptance and Commitment Therapy for Couples With Fear of Lung Cancer Recurrence
Fujian Medical University
Clinical Study on the Effects of Pulmonary Vessels on Cryoablation and Preventive Embolization Strategies
First Hospital of China Medical University
Application of Electromagnetic Navigation System in Pulmonary Nodule Localization
Shanghai Pulmonary Hospital, Shanghai, China
Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
SUNRISE
AdventHealth Translational Research Institute
UNIFIER
University of Florida
A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors
Beijing DCTY Biotech Co.,Ltd.
Preoperative Decision-Making in Patients With Pulmonary Nodules Suspected of Lung Cancer
Sichuan Cancer Hospital and Research Institute
ECHO
AstraZeneca
XR-NeckLND
National Taiwan University Hospital
TCR1188-ABC Cells in KRAS-mutated Cancers
University of Pennsylvania
SPARC
University of Utah